1. Home
  2. GNPX vs MKZR Comparison

GNPX vs MKZR Comparison

Compare GNPX & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • MKZR
  • Stock Information
  • Founded
  • GNPX 2009
  • MKZR 2012
  • Country
  • GNPX United States
  • MKZR United States
  • Employees
  • GNPX N/A
  • MKZR N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • MKZR
  • Sector
  • GNPX Health Care
  • MKZR
  • Exchange
  • GNPX Nasdaq
  • MKZR Nasdaq
  • Market Cap
  • GNPX 9.1M
  • MKZR 10.3M
  • IPO Year
  • GNPX 2018
  • MKZR N/A
  • Fundamental
  • Price
  • GNPX $0.23
  • MKZR $0.50
  • Analyst Decision
  • GNPX
  • MKZR
  • Analyst Count
  • GNPX 0
  • MKZR 0
  • Target Price
  • GNPX N/A
  • MKZR N/A
  • AVG Volume (30 Days)
  • GNPX 1.1M
  • MKZR 566.1K
  • Earning Date
  • GNPX 08-12-2025
  • MKZR 08-15-2025
  • Dividend Yield
  • GNPX N/A
  • MKZR 44.87%
  • EPS Growth
  • GNPX N/A
  • MKZR N/A
  • EPS
  • GNPX N/A
  • MKZR N/A
  • Revenue
  • GNPX N/A
  • MKZR $23,037,348.00
  • Revenue This Year
  • GNPX N/A
  • MKZR N/A
  • Revenue Next Year
  • GNPX N/A
  • MKZR N/A
  • P/E Ratio
  • GNPX N/A
  • MKZR N/A
  • Revenue Growth
  • GNPX N/A
  • MKZR 52.64
  • 52 Week Low
  • GNPX $0.20
  • MKZR $0.50
  • 52 Week High
  • GNPX $3.97
  • MKZR $5.50
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 39.16
  • MKZR N/A
  • Support Level
  • GNPX $0.25
  • MKZR N/A
  • Resistance Level
  • GNPX $0.29
  • MKZR N/A
  • Average True Range (ATR)
  • GNPX 0.02
  • MKZR 0.00
  • MACD
  • GNPX -0.01
  • MKZR 0.00
  • Stochastic Oscillator
  • GNPX 12.22
  • MKZR 0.00

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

Share on Social Networks: